0000000000850095
AUTHOR
Javier Zarranz-ventura
Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
Abstract Objective Minimize exposure to the SARS-CoV-2, reduce the chances of cross-transmission between patients and healthcare personnel, and prevent the development of postoperative complications from the management of patients with eye diseases during the 2019 coronavirus disease pandemic (COVID-19). Methods COVID-19 literature review and consensus establishment between different Spanish ophthalmology societies in order to provide guidelines and recommendations of maximum resources primarily conditioned by the state of alert, confinement and social distancing that occurs in Spain since March 16, 2020. Results The recommendations will promote the adoption of action and protection measure…
Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19
Resumen Objetivo Minimizar la exposicion al virus SARS-CoV-2, reducir las posibilidades de transmision cruzada entre pacientes y personal sanitario, y evitar el desarrollo de complicaciones postoperatorias por la atencion a pacientes con enfermedades oculares durante la pandemia de enfermedad por coronavirus 2019 (COVID-19). Metodos Elaboracion de un documento de revision del estado del conocimiento sobre COVID-19 y consenso entre diferentes sociedades oftalmologicas espanolas y afines, al objeto de proporcionar guias y recomendaciones de maximos recursos primariamente condicionadas por el estado de alerta, confinamiento y distanciamiento social que acontece en Espana desde el 16 de marzo d…
Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical Practice: the Fight Retinal Blindness! Registry
To evaluate the proportion, baseline predictors, and outcomes of neovascular age-related macular degeneration (nAMD) patients treated with a high burden of vascular endothelial growth factor (VEGF) inhibitor intravitreal injections (IVT) at two years in routine clinical practice. European retrospective data analysis from a prospectively designed observational outcomes registry: the Fight Retinal Blindness! (FRB!) Project. Treatment-naïve eyes (one eye per patient) initiating VEGF inhibitors IVT from January 2017 to March 2020 with 24 months of follow-up, a minimum of 3 injections, and no gap between visits exceeding 365 days were tracked in the registry. We analyzed three treatment burden (…